BRUSSELS/FRANKFURT/PARIS (dpa-AFX) - SK bioscience Co. (302440.KS) reported a first quarter net loss attributable to shareholders of parent company of 33.3 billion korean won compared to a loss of 7.5 billion won, last year. Operating loss widened to 44.5 billion won compared to a loss of 15.1 billion won.
First quarter sales were 168.6 billion Korean won compared to 154.6 billion won, prior year, up 9.1%.
Shares of SK bioscience are trading at 44,100 won, up 1.85%.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com.
Copyright(c) 2026 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
© 2026 AFX News
